insightSLICE.png
Artificial Organs Market Sales Are Expected To Surpass US$ 35 Billion by 2030, As Stated by insightSLICE
January 20, 2021 10:31 ET | insightSLICE
PUNE, India, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Global Artificial Organs Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies,...
RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
September 15, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare_FullLogo_RGB-full.png
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration
July 01, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., July 01, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the official launch of its new RenovaCare R&D Innovation Center in...
RenovaCare Strengthens FDA Program with Leading U.S. Regulatory Group and Significant Investment
May 28, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London
March 30, 2020 08:32 ET | RenovaCare, Inc.
ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare_FullLogo_RGB-full.png
RenovaCare Announces New Corporate Headquarters and Laboratory Facilities
March 11, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced new corporate headquarters in Roseland, New Jersey and laboratory...
RenovaCare Stockholder Update and 2020 Outlook from the CEO
December 05, 2019 08:30 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other...
Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare
November 26, 2019 08:30 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., Nov. 26, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare
September 24, 2019 08:30 ET | RenovaCare, Inc.
SCOTTSDALE, Ariz., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...